Journal
ANGIOLOGY
Volume 65, Issue 10, Pages 919-926Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/0003319713512414
Keywords
hypercholesterolemia; lipids; low-density lipoprotein; cardiovascular; coronary; guidelines; Arabian Gulf countries
Categories
Funding
- AstraZeneca
Ask authors/readers for more resources
The Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS) survey evaluated the attainment of low-density lipoprotein cholesterol (LDL-C) goals among patients on lipid-lowering drugs (LLDs) according to the updated National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP-III) guideline. The survey was conducted in 6 Arabian Gulf countries. Patients aged >= 18 years on LLDs for at least >= 3 months (stable medication for >= 6 weeks) were recruited. Fasting blood samples were collected at a single visit. In this survey, 5276 (58.2% male) patients were included in the final analysis. The LDL-C goal was attained in 91.1% of low-risk, 52.7% of high-risk, and 32.0% in very-high-risk categories. Goal attainment was directly related to female gender, age < 40 years, history of diabetes, and family history of cardiovascular disease. The results of this survey highlight the suboptimal management of hypercholesterolemia across Arabian Gulf countries.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available